PRO

The Psychedelic Education Market is Expanding Rapidly

This rapid expansion is occurring in response to growth— both real and perceived- in the greater psychedelic and mental health treatment industries. The Neuly EDU Course Directory went from 90 courses listed a few years ago to over 450 today.

The first half of 2023 has come to an end, and so far, this year has been just as action-packed as 2022. The first two quarters of the year have been full of first-of-their-kind clinical trials and psychedelic research, new businesses, failed businesses, altered perceptions, and certainly tons of passion. The second quarter, in particular, has been full of breaking news and important developments in the psychedelic sector.  There has been a lot going on in the industry this year. But, if we were to sum up the momentum into one sentence, it would be this: preparation for the commercialization of MDMA. 

This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the psychedelic industry. 

Of all the major developments, the release of the MAPP2 phase III clinical trial results was the biggest. The founder and president of MAPS is like the father of the modern psychedelic industry. Most companies in this space have only been around for about 3-5 years. However, Rick Doblin started MAPS 38 years ago. 

Subscribe to a PRO account below for complete access to the report.

The first half of 2023 has come to an end, and so far, this year has been just as action-packed as 2022. The first two quarters of the year have been full of first-of-their-kind clinical trials and psychedelic research, new businesses, failed businesses, altered perceptions, and certainly tons of passion. The second quarter, in particular, has been full of breaking news and important developments in the psychedelic sector.  There has been a lot going on in the industry this year. But, if we were to sum up the momentum into one sentence, it would be this: preparation for the commercialization of MDMA.